Search Results
Found 1 results
510(k) Data Aggregation
(121 days)
The FlexStent® Biliary Self Expanding Stent System is indicated for use in the palliation of malignant strictures in the biliary tree.
Not Found
The provided document is a 510(k) premarket notification letter from the FDA for the FlexStent® Biliary Self Expanding Stent System. It approves the device as substantially equivalent to legally marketed predicate devices for the palliation of malignant strictures in the biliary tree.
However, the document does not contain any information regarding acceptance criteria, device performance studies, sample sizes, ground truth establishment, expert qualifications, or MRMC studies. The letter is an approval based on a substantial equivalence determination, not a detailed report of clinical study results.
Therefore, I cannot fulfill your request for the specific information laid out in your prompt based on the provided text. The document confirms the regulatory approval for marketing, but it does not detail the technical performance and study design data that would typically be found in a clinical study report or a more comprehensive FDA submission summary.
Ask a specific question about this device
Page 1 of 1